Universal Medical Financial & Technical Advisory Services Company Limited (“Universal Medical”, HK.2666) enters into a $600mn overseas syndicated loan agreement on December 11, 2017, which is the first syndicated loan of the Company with Universal Medical as the borrower and the largest single financing project it has ever made.0

The 3-year term, Libor/Hibor+1.60% syndicated loan, leading banks including China Construction Bank (Asia), Chinatrust Commercial Bank and Shanghai Pudong Development Bank Hong Kong Branch, attracts more than 20 overseas banks, e.g., China Construction Bank (Asia), Chinatrust Commercial Bank, Shanghai Pudong Development Bank Hong Kong Branch, Bank of Communications Hong Kong Branch, Chong Hing Bank, Hang Seng Bank, State Bank of India and Tokyo Star Bank. The capital from the syndicated loan is intended to be used for healthcare business of the Company.

Funding cost has been growing due to tightened liquidity since the end of 2016. While carrying out various domestic financing projects, Universal Medical still paid sustained attention to overseas financing climate for appropriate time window so as to better restructuring and efficient resources.

Senior management said that Universal Medical, as a leading integrated healthcare services provider, accumulated years of industrial experience and enjoyed sustained growth and excellent asset quality, which was highly recognized by domestic and overseas financial institutions. The syndicated loan marks our another great step for more overseas financing channels and lower overall funding cost.